Literature DB >> 12853706

Why thrombin generation? From bench to bedside.

Louis M Aledort1.   

Abstract

Intervention for clotting and bleeding disorders is costly, and clear-cut regimens undefined. The margin of safety between hemostasis and thrombosis is narrow and unpredictable. The use of a laboratory test to help define therapeutic regimens, dissect effects of these treatments, and to differentiate them are clearly needed. The current state of the art of thrombin generation is ready to do this. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853706     DOI: 10.1159/000071635

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  4 in total

Review 1.  Empirical and theoretical phenotypic discrimination.

Authors:  K E Brummel-Ziedins; T Orfeo; F R Rosendaal; A Undas; G E Rivard; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

2.  Assessing thrombin generation at the point of care.

Authors:  T Keith Brock; Nicole L Gentile; Richard F Louie; Nam K Tran; Tyler Kitano; Gerald J Kost
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

Review 3.  Computationally Driven Discovery in Coagulation.

Authors:  Kathryn G Link; Michael T Stobb; Dougald M Monroe; Aaron L Fogelson; Keith B Neeves; Suzanne S Sindi; Karin Leiderman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

4.  Global coagulation assays in hemophilia A: A comparison to conventional assays.

Authors:  Saman Aghighi; Anne Riddell; Christine A Lee; Simon A Brown; Edward Tuddenham; Pratima Chowdary
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.